// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A UK centre based review of tuberculosis post kidney transplantation

Kavina Manalan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Isoniazid

TB following targeted and biological therapy: can we predict it?

John Cafferkey - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon Gamma

Thoracic ultrasound (TUS training: Regional survey of respiratory specialty trainees (RST from West Midlands Deanery (WMD, UK

Qaiser Abdullah - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Use of safety checklists for pleural procedures by Respiratory trainees

Qaiser Abdullah - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diaphragm ultrasound examination before and after fluid drainage in patients with malignant pleural effusion

Olalla Castro-Anon - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diagnostic yield and safety of image-guided pleural biopsy: a systematic review and meta-analysis

Federico Mei - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes

Ireti Adejumo - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Engaging younger people in their asthma management – findings from a pilot telemedicine asthma nurse service

Andrew Cumella - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A Patient Feedback Driven, Stacked Machine-Learning Approach to At-Home COPD Triage

Sumanth Swaminathan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data

Shauna McKibben - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

RECEIVER trial: positive early experience and sustained patient engagement with a digital service model for COPD management

Anna Taylor - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

What features do patients and clinicians ‘want’ in the future Internet-Of-Things (IoT systems for asthma: a mixed method study

Chi Yan Hui - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Repeated exposure to hydrogen peroxide enhances TGF-ß and LPS dependent inflammatory responses in BEAS-2B cells

Fawziye Tarhini - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Hydrogen peroxide

Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort

Angelica Tiotiu - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Asthma

Interferon Gamma

Mouse tracheal epithelial cells (mTECs for the study of influenza A infectio>

Fawaz ALJuhani - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

Interferon

Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD

Ahmed Javid Yousuf - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Fibrinogen (IV)

Does declining nutritional status in ataxia telangiectasia cause decline in immunological function

Suha Ugur - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ataxia telangiectasia

13-valent pneumococcal conjugate vaccine

Central and obstructive apnoea-hypopnea indices pre and post growth hormone commencement in children with Prader-Willis syndrome following introduction of a screening programme

Damilola Modupe Oladele - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

hGH

A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism

Christopher C Huntley - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Subsegmental pulmonary emboli

Hydroxyzine

Haploid genetic screening identifies a novel regulator of BMPR2

Benjamin Dunmore - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

chloroquine

Copyright © 2026. QuantiNova All rights reserved